Quick Answer
ANI PHARMACEUTICALS INC reported Stockholders Equity of $540.72 million for fiscal year 2025.
ANI PHARMACEUTICALS INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $540.72M | +33.9% |
| 2024 | $403.68M | -6.7% |
| 2023 | $432.75M | +38.0% |
| 2022 | $313.69M | -6.0% |
| 2021 | $333.89M | +70.6% |
| 2020 | $195.70M | -8.0% |
| 2019 | $212.79M | +7.9% |
| 2018 | $197.26M | +12.9% |
| 2017 | $174.76M | +3.0% |
| 2016 | $169.65M | +6.0% |
| 2015 | $160.08M | +14.5% |
| 2014 | $139.78M | +241.3% |
| 2013 | $40.96M | +195.9% |
| 2012 | -$42.72M | -24.6% |
| 2011 | -$34.28M | -279.1% |
| 2010 | $19.15M | +21.0% |
| 2009 | $15.83M | +14.5% |
| 2008 | $13.83M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $505.82M | +24.6% | +15.8% |
| June 30, 2025 | $436.76M | -4.2% | +4.3% |
| March 31, 2025 | $418.62M | -7.4% | +3.7% |
| December 31, 2024 | $403.68M | -6.7% | -0.6% |
| September 30, 2024 | $405.95M | -5.6% | -10.9% |
| June 30, 2024 | $455.76M | +11.3% | +0.8% |
| March 31, 2024 | $451.96M | +43.6% | +4.4% |
| December 31, 2023 | $432.75M | +38.0% | +0.7% |
- ANI PHARMACEUTICALS INC showed an increase of +33.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, ANI PHARMACEUTICALS INC’s stockholders equity has grown by 3810.8% (from $13.83 million to $540.72 million).
- The most recent figure is from ANI PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: